| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2008 | US20080004283 Pharmaceutical Compositions for the Treatment of Cellulite |
| 01/03/2008 | US20080004282 Compositions and methods for modulating gated ion channels |
| 01/03/2008 | US20080004281 Methods for the modulation of crp by the selective modulation of ppar delta |
| 01/03/2008 | US20080004280 Heterocyclic topoisomerase poisons |
| 01/03/2008 | US20080004279 Use of C-Kit Inhibitors for Treating Plasmodium Related Diseases |
| 01/03/2008 | US20080004278 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 01/03/2008 | US20080004277 Triazole compounds that modulate HSP90 activity |
| 01/03/2008 | US20080004276 Method for treating non-hodgkin's lymphoma |
| 01/03/2008 | US20080004275 Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds |
| 01/03/2008 | US20080004274 Novel biaromatic compounds that modulate PPAR type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/03/2008 | US20080004273 Inhibitors of VEGF and HGF receptor signaling; treating cell proliferative diseases; N-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-oxo-1-phenylpyrrolidine-3-carboxamide |
| 01/03/2008 | US20080004272 Compositions and methods for modulating gated ion channels |
| 01/03/2008 | US20080004271 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith |
| 01/03/2008 | US20080004270 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors |
| 01/03/2008 | US20080004269 Pyrazolylmethy Heteroaryl Derivatives |
| 01/03/2008 | US20080004268 e.g. 4-tert-Butyl-N-[3-phenyl-2-(pyrrolidine-1-carbonyl)-1H-indol-5-yl]-benzenesulfonamide; contraceptive; for male fertility control; act on testicular stem cells and mature sperm |
| 01/03/2008 | US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004266 Method for treating proliferative disorders associated with protooncogene products |
| 01/03/2008 | US20080004265 HIV Integrase Inhibitors |
| 01/03/2008 | US20080004264 Rapamycin analogues and the uses thereof in the treatment of neurological disorders |
| 01/03/2008 | US20080004263 Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof |
| 01/03/2008 | US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period |
| 01/03/2008 | US20080004261 Calcitonin Gene-Related Peptide (CGRP); headaches, pain, hot flashes; compounds are based on 3-substituted-5-(piperidinocarbonylmethyl)-thiazolidin-4-one moiety and ring derivatives thereof |
| 01/03/2008 | US20080004260 Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
| 01/03/2008 | US20080004259 Anticancer agents; initiating mitosis which causes tumor cell death |
| 01/03/2008 | US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders |
| 01/03/2008 | US20080004257 Kinase inhibitors |
| 01/03/2008 | US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors |
| 01/03/2008 | US20080004255 Methods and compositions for altering cell function |
| 01/03/2008 | US20080004254 Compositions for weight management |
| 01/03/2008 | US20080004253 Thiazolopyrimidine modulators of TRPV1 |
| 01/03/2008 | US20080004252 3-(3,4-Dichloro-phenoxy)-8-(1H-tetrazol-5-ylmethyl)-8-aza-bicyclo[3.2.1]octane; Central nervous system disorders |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080004250 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/03/2008 | US20080004249 Chemical Compounds |
| 01/03/2008 | US20080004248 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases |
| 01/03/2008 | US20080004247 Combinations of Statins with Bronchodilators |
| 01/03/2008 | US20080004246 Transporter enhanced corticosteroid activity |
| 01/03/2008 | US20080004245 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 01/03/2008 | US20080004244 Phosphono-carboxylate compounds for treating amyloidosis |
| 01/03/2008 | US20080004243 Method for predicting susceptibility to radiation pneumonitis |
| 01/03/2008 | US20080004242 Process for preparation of HIV protease inhibitors |
| 01/03/2008 | US20080004241 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | US20080004239 Boronated Metal-Phthalocyanines, Process For Their Preparation, Pharmaceutical Compositions Comprising Them And Use Thereof |
| 01/03/2008 | US20080004238 Composition and Method for Treating Connective Tissue Damage by Transmucosal Administration |
| 01/03/2008 | US20080004237 Utilizing prodrug technique to couple polysaccharides containing galactose with a parent compound through different bridge linkage to derive conjugates; polysaccharide component protects 5-fluorouracil(5-FU) from absorption in the upper gastrointestinal tract, delivers the 5-FU to colorectal area |
| 01/03/2008 | US20080004236 High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections |
| 01/03/2008 | US20080004235 Topical compositions comprising one or more of 4-thiouridine, isomaltitol and uridine |
| 01/03/2008 | US20080004233 Delta-Tocotrienol Treatment and Prevention of Pancreatic Cancer |
| 01/03/2008 | US20080004232 Characterization of c19orf10, a Novel Synovial Protein |
| 01/03/2008 | US20080004231 Disease-Associated Protein |
| 01/03/2008 | US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor |
| 01/03/2008 | US20080004228 New Expression Tools for Multiprotein Applications |
| 01/03/2008 | US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level |
| 01/03/2008 | US20080004226 Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of Diabetes |
| 01/03/2008 | US20080004225 New dialysis method |
| 01/03/2008 | US20080004214 Injectable collagen material |
| 01/03/2008 | US20080004210 Diagnostic markers for ischemia |
| 01/03/2008 | US20080003682 treatment or prevention of infection through the expression of one or more RNA molecules that inhibit one or more aspects of the life cycle of a pathogen through RNA interference with a target nucleic acid; for human lymphadenopathy associated viral diseases |
| 01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
| 01/03/2008 | US20080003658 Method for expression of small antiviral rna molecules within a cell |
| 01/03/2008 | US20080003636 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent |
| 01/03/2008 | US20080003620 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
| 01/03/2008 | US20080003308 Composition Based on Vegetal Extracts of Ajuga Reptans for Preventing Hair Loss, Stimulating the Growth of Hair, Regulating the Production of Sebum |
| 01/03/2008 | US20080003306 Compositions for weight management |
| 01/03/2008 | US20080003304 Combination chemotherapy |
| 01/03/2008 | US20080003303 Nutraceutical treatments for diabetic and non-diabetic wound healing |
| 01/03/2008 | US20080003302 Method And Nutraceutical Composition For Mammals |
| 01/03/2008 | US20080003300 Compostions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory Cytokines (a combination of a Free-B-Ring flavonoids and a flavan) for osteoporosis prevention, therapy and treatment of bone diseases |
| 01/03/2008 | US20080003297 Taste-masking oral dosage form and method of preparing the same |
| 01/03/2008 | US20080003295 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | US20080003288 Responsive microgel and methods related thereto |
| 01/03/2008 | US20080003286 Sustained delivery alfuzosin compositions |
| 01/03/2008 | US20080003284 Levothyroxine compositions and methos |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003281 Modified Release Tablet Formulations for Proton Pump Inhibitors |
| 01/03/2008 | US20080003280 Combination cough treatment compounds and method of treating common coughs |
| 01/03/2008 | US20080003279 Coenzyme Q10 Formulation and Process Methodology for Soft Gel Capsules Manufacturing |
| 01/03/2008 | US20080003278 Food products and dietary supplements for improving mental performance |
| 01/03/2008 | US20080003277 Agent for improving tissue penetration |
| 01/03/2008 | US20080003276 Glucocoricoid is an amphipathic weak acid or base such as methylprednisolone sodium hemisuccinate encapsulated in a liposome; treating rheumatoid arthritis or other autoimmune disease, provided they are not neurodegenerative disorders |
| 01/03/2008 | US20080003275 Treatment of Premature Ejaculation |
| 01/03/2008 | US20080003273 Transdermal Delivery of Oleocanthal for Relief of Inflammation |
| 01/03/2008 | US20080003271 Moisturizing, cosmetic, or anti-wrinkle composition comprising at least two hyaluronic acid fractions or salts thereof, wherein first fraction has molecular weight of 8,000-100,000 Da, and second fraction has molecular weight of 500,000-1,100,000 Da; may also have use in treating osteoarthritis, cancer |
| 01/03/2008 | US20080003268 Unit serving appetite suppressant compositions with steroidal glycosides |
| 01/03/2008 | US20080003267 Pharmaceutical Composition |
| 01/03/2008 | US20080003266 Composition Comprising Statins |
| 01/03/2008 | US20080003262 Compositions and therapeutic methods of use |
| 01/03/2008 | US20080003260 Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |
| 01/03/2008 | US20080003258 Composition and Method for Treating Rheumatoid Arthritis |
| 01/03/2008 | US20080003257 Composition and Method for Treating Connective Tissue Damage |
| 01/03/2008 | US20080003254 Systems and methods for delivering a rapamycin analog that do not inhibit human coronary artery endothelial cell migration |
| 01/03/2008 | US20080003253 Block copolymers including a methoxyethyl methacrylate midblock |
| 01/03/2008 | US20080003251 Coatings for medical devices comprising a therapeutic agent and a metallic material |
| 01/03/2008 | US20080003250 Novel therapy for herpesvirus infection |
| 01/03/2008 | US20080003246 Self-Neutralizing Acid Peel for Dermatologic Use |
| 01/03/2008 | US20080003244 Inflammation and Oxidative Stress Reducing Compostion for Topical or Oral Administration |
| 01/03/2008 | US20080003232 Cpg Single Strand Deoxynucleotides for Use as Adjuvant |
| 01/03/2008 | US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof |